H18.559 Macular corneal dystrophy, unspecified eye

Name of the Condition

• Macular corneal dystrophy, unspecified eye

Summary

Macular corneal dystrophy is a rare genetic disorder that affects the cornea, the clear front surface of the eye. It is characterized by progressive clouding and opacity of the cornea due to abnormal deposits of glycosaminoglycans, leading to visual impairment. The condition typically presents in childhood or early adulthood and may worsen over time. When unspecified, the diagnosis applies to either eye or both eyes without specifying laterality.

Causes

The primary cause is genetic mutations, often inherited in an autosomal recessive pattern, that disrupt the production or processing of corneal stromal proteins. These mutations lead to the accumulation of abnormal substances in the corneal tissue, causing structural changes and opacity.

Risk Factors

• Family history of macular corneal dystrophy.
• Genetic predisposition due to inherited mutations.

Symptoms

• Blurred or reduced vision.
• Sensitivity to light (photophobia).
• Eye pain or discomfort.
• Corneal clouding or opacity.
• Difficulty with night vision or glare.

Diagnosis

A comprehensive eye examination by an ophthalmologist is essential. Diagnosis may involve slit-lamp examination to assess corneal opacity, corneal topography or tomography to map structural changes, and genetic testing to confirm the presence of specific mutations. Clinical evaluation focuses on identifying characteristic corneal deposits and ruling out other causes of corneal opacity.

Treatment Options

• Corneal transplantation (penetrating keratoplasty) to replace the affected corneal tissue.
• Phototherapeutic keratectomy (PTK) to remove superficial corneal opacities in early stages.
• Refractive correction (glasses, contact lenses) to manage visual impairment.
• Monitoring for disease progression and complications.

Prognosis and Follow-Up

Prognosis depends on the severity of corneal involvement and response to treatment. Corneal transplantation may improve vision, but recurrence of deposits in the graft is possible. Regular follow-up with an ophthalmologist is necessary to monitor visual function, graft health, and potential complications.

Complications

• Progressive vision loss.
• Corneal scarring or thinning.
• Graft rejection or failure after transplantation.
• Increased risk of corneal infections.

Lifestyle & Prevention

• Protect eyes from injury and UV exposure.
• Maintain regular eye examinations to detect early changes.
• Genetic counseling for affected families to assess inheritance risks.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden vision loss, severe eye pain, increased sensitivity to light, or signs of corneal infection (e.g., redness, discharge). Regular ophthalmologic care is recommended for ongoing monitoring.

Tips for Medical Coders

Document the eye laterality (right, left, or bilateral) when specified. For unspecified eye, use H18.559. Ensure clinical documentation supports the diagnosis, including corneal examination findings, genetic testing results, or family history if available. Verify that the code aligns with the patient’s clinical presentation and avoid using this code for other corneal dystrophies or non-dystrophic conditions.